Literature DB >> 19322675

Reversal of glycogen storage disease type IIIa-related cardiomyopathy with modification of diet.

A I Dagli1, R T Zori, H McCune, T Ivsic, M K Maisenbacher, D A Weinstein.   

Abstract

Glycogen storage disease type III (GSD III) is caused by a deficiency in debranching enzyme, which leads to an accumulation of abnormal glycogen called limit dextrin in affected tissues. Muscle and liver involvement is present in GSD type IIIa, while the defect is limited to the liver only in GSD type IIIb. Besides skeletal muscle involvement, a cardiomyopathy resembling idiopathic hypertrophic cardiomyopathy is seen. Management consists of maintaining normoglycaemia by supplementation with cornstarch therapy and/or protein. While studies are lacking regarding the best treatment for skeletal muscle disease, a high-protein diet was previously reported to be beneficial. No cases of improvement in cardiomyopathy have been reported. Our patient presented in infancy with hypoglycaemia and hepatomegaly. His prescribed management consisted of cornstarch supplementation and a high-protein diet providing 20% of his total energy needs. At 16 years of age, he developed a severe cardiomyopathy with a left ventricular mass index of 209 g/m(2). The cardiomyopathy remained stable on a protein intake of 20-25% of total energy. At age 22 years, the diet was changed to increase his protein intake to 30% of total energy and minimize his cornstarch therapy to only what was required to maintain normoglycaemia. Dramatic improvement in the cardiomyopathy occurred. Over one year, his left ventricular mass index decreased from 159.7 g/m(2) to 78 g/m(2) (normal 50-86 g/m(2)) and the creatine kinase levels decreased from 455 U/L to 282 U/L. Avoidance of overtreatment with carbohydrate and a high-protein diet can reverse and may prevent cardiomyopathy.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19322675      PMCID: PMC3808093          DOI: 10.1007/s10545-009-1088-x

Source DB:  PubMed          Journal:  J Inherit Metab Dis        ISSN: 0141-8955            Impact factor:   4.982


  21 in total

Review 1.  Glycogen storage diseases.

Authors:  Joseph I Wolfsdorf; David A Weinstein
Journal:  Rev Endocr Metab Disord       Date:  2003-03       Impact factor: 6.514

2.  [Glycogenosis type III myocardiopathy].

Authors:  A M Rossignol; M Meyer; B Rossignol; M P Palcoux; E J Raynaud; M Bost
Journal:  Arch Fr Pediatr       Date:  1979-03

3.  Debranching enzyme from rabbit skeletal muscle; evidence for the location of two active centres on a single polypeptide chain.

Authors:  E J Bates; G M Heaton; C Taylor; J C Kernohan; P Cohen
Journal:  FEBS Lett       Date:  1975-10-15       Impact factor: 4.124

4.  Reversible severe myopathy of respiratory muscles due to adult-onset type III glycogenosis.

Authors:  S Kiechl; J Willeit; W Vogel; U Kohlendorfer; W Poewe
Journal:  Neuromuscul Disord       Date:  1999-10       Impact factor: 4.296

5.  Gross cardiac involvement in glycogen storage disease type 3.

Authors:  C G Miller; G A Alleyne; S E Brooks
Journal:  Br Heart J       Date:  1972-08

6.  Cardiac involvement in glycogen storage disease III: morphologic and biochemical characterization with endomyocardial biopsy.

Authors:  L J Olson; G S Reeder; K L Noller; W D Edwards; R R Howell; V V Michels
Journal:  Am J Cardiol       Date:  1984-03-15       Impact factor: 2.778

7.  Type III glycogenosis presenting as liver disease in adults with atypical histological features.

Authors:  I W Fellows; J S Lowe; A L Ogilvie; A Stevens; P J Toghill; M Atkinson
Journal:  J Clin Pathol       Date:  1983-04       Impact factor: 3.411

8.  Debrancher deficiency: neuromuscular disorder in 5 adults.

Authors:  S DiMauro; G B Hartwig; A Hays; A B Eastwood; R Franco; M Olarte; M Chang; A D Roses; M Fetell; R S Schoenfeldt; L Z Stern
Journal:  Ann Neurol       Date:  1979-05       Impact factor: 10.422

9.  Reversal of debrancher deficiency myopathy by the use of high-protein nutrition.

Authors:  A E Slonim; C Weisberg; P Benke; O B Evans; I M Burr
Journal:  Ann Neurol       Date:  1982-04       Impact factor: 10.422

10.  Myopathy and growth failure in debrancher enzyme deficiency: improvement with high-protein nocturnal enteral therapy.

Authors:  A E Slonim; R A Coleman; W S Moses
Journal:  J Pediatr       Date:  1984-12       Impact factor: 4.406

View more
  19 in total

1.  Cardiac Pathology in Glycogen Storage Disease Type III.

Authors:  S L Austin; A D Proia; M J Spencer-Manzon; J Butany; S B Wechsler; P S Kishnani
Journal:  JIMD Rep       Date:  2012-01-31

2.  Heart Failure Due to Severe Hypertrophic Cardiomyopathy Reversed by Low Calorie, High Protein Dietary Adjustments in a Glycogen Storage Disease Type IIIa Patient.

Authors:  Christiaan P Sentner; Kadir Caliskan; Wim B Vletter; G Peter A Smit
Journal:  JIMD Rep       Date:  2011-12-13

3.  Pregnancy and its management in women with GSD type III - a single centre experience.

Authors:  Radha Ramachandran; Yehani Wedatilake; Caroline Coats; Fiona Walker; Perry Elliott; Philip J Lee; Robin H Lachmann; Elaine Murphy
Journal:  J Inherit Metab Dis       Date:  2011-09-07       Impact factor: 4.982

4.  A founder AGL mutation causing glycogen storage disease type IIIa in Inuit identified through whole-exome sequencing: a case series.

Authors:  Isabelle Rousseau-Nepton; Minoru Okubo; Rosemarie Grabs; John Mitchell; Constantin Polychronakos; Celia Rodd
Journal:  CMAJ       Date:  2015-01-19       Impact factor: 8.262

5.  Rescue of GSDIII Phenotype with Gene Transfer Requires Liver- and Muscle-Targeted GDE Expression.

Authors:  Patrice Vidal; Serena Pagliarani; Pasqualina Colella; Helena Costa Verdera; Louisa Jauze; Monika Gjorgjieva; Francesco Puzzo; Solenne Marmier; Fanny Collaud; Marcelo Simon Sola; Severine Charles; Sabrina Lucchiari; Laetitia van Wittenberghe; Alban Vignaud; Bernard Gjata; Isabelle Richard; Pascal Laforet; Edoardo Malfatti; Gilles Mithieux; Fabienne Rajas; Giacomo Pietro Comi; Giuseppe Ronzitti; Federico Mingozzi
Journal:  Mol Ther       Date:  2017-12-28       Impact factor: 11.454

Review 6.  Inborn errors of energy metabolism associated with myopathies.

Authors:  Anibh M Das; Ulrike Steuerwald; Sabine Illsinger
Journal:  J Biomed Biotechnol       Date:  2010-05-26

Review 7.  Dietary management in glycogen storage disease type III: what is the evidence?

Authors:  Terry G J Derks; G Peter A Smit
Journal:  J Inherit Metab Dis       Date:  2014-08-28       Impact factor: 4.982

8.  Natural Progression of Canine Glycogen Storage Disease Type IIIa.

Authors:  Elizabeth D Brooks; Haiqing Yi; Stephanie L Austin; Beth L Thurberg; Sarah P Young; John C Fyfe; Priya S Kishnani; Baodong Sun
Journal:  Comp Med       Date:  2016-02       Impact factor: 0.982

9.  Improvement of Cardiomyopathy After High-Fat Diet in Two Siblings with Glycogen Storage Disease Type III.

Authors:  Alessandra Brambilla; Savina Mannarino; Roberta Pretese; Serena Gasperini; Cinzia Galimberti; Rossella Parini
Journal:  JIMD Rep       Date:  2014-10-12

10.  Characterization of a canine model of glycogen storage disease type IIIa.

Authors:  Haiqing Yi; Beth L Thurberg; Sarah Curtis; Stephanie Austin; John Fyfe; Dwight D Koeberl; Priya S Kishnani; Baodong Sun
Journal:  Dis Model Mech       Date:  2012-06-26       Impact factor: 5.758

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.